Inhibitor

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

Anticoagulation in Pregnant Women: Which Medications are Safe?

By: Diana Gritsenko, PharmD Candidate 2015 - Multiple complications can arise during pregnancy. While venous thromboembolism (VTE) has a prevalence…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Long Term PPI Use Heightens Concern of Associated Health Consequences

By: Tamara Yunusova, Senior Staff Editor - Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the…

12 years ago

BRD4 Inhibition Eliminates Malignant Peripheral Nerve Sheath Tumor in Mice

By: Richard Chung, PharmD Candidate c/o 2017 - Malignant peripheral nerve sheath tumor, otherwise known commonly as MPNST, is an…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

A Close Concurrence on Certolizumab (Cimzia®)

By: Sang Hyo Kim, Staff Editor - This year, on July 23rd, FDA advisers voted 7 to 6, with one…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

A Look at Primary Medication NonAdherence and How it can be Overcome

By:  Erica Dimitropoulos, Assistant Student Editor - Although clinical trials can affirm the efficacy and advantages of all marketed medications,…

13 years ago

Emerging Pathways For Treating Hepatitis C Virus

By:  Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

SSRI Discontinuation Syndrome

By: Shannon Tellier, PharmD Candidate c/o 2013 - Antidepressant discontinuation syndrome has been reported in all categories of antidepressants after…

14 years ago

Low-dose SSRIs for the Overly Sensitive Esophagus

By Sunhae Chang, PharmD Candidate c/o 2013 - When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux…

14 years ago

Duloxetine’s Effect on Blood Glucose Levels

By: Neal Shah, Co-Editor-in-Chief - Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US…

14 years ago

Medications Causing Body Temperature Fluctuations

By: Elsa Thomas, Pharm.D. c/o 2013 - Human body uses various complex mechanisms to maintain its body temperature within a…

14 years ago

Antiplatelet Use Following Acute Coronary Syndromes

By: Addolorata Ciccone, Co-Copy Editor - Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

Use of Donepezil in Patients with Delirium (but without Dementia)

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Donepezil, brand name Aricept®, is an acetylcholinesterase inhibitor indicated as monotherapy…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Risk versus Benefit: Prescription to Over the Counter Medications

By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 -   Maria Sorbera was the 2011-2012 President of the Rho Chi…

14 years ago

Proton Pump Inhibitor Use and Complications

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 - We see proton pump inhibitors (PPIs) used in many medication regimens, but…

14 years ago

Role of Calcium Channel Blockers and Beta Blockers in CHF

By: Lunbao Huang Pharm D. Candidate c/o 2013 - The seventh report of the Joint National Committee on high blood…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

Proton Pump Inhibitors and the Treatment of Osteoporosis

By: Neal Shah - Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

Ivabradine: A Novel I(f) Blocker for Stable Angina

By: Neal Shah - Part I:              Preface. Part II:             Brief review of cardiac electrophysiology. Part III:           Ivabradine as a novel…

15 years ago

Event Spotlight: “Who Wants to be a PharmD?” Game Show

By: Marie Huang - As the studio lights dimmed and the dynamic music played in the background, many students gathered…

15 years ago

Faculty Spotlight: Dr. Charles R. Ashby

By: Neal Shah - Dr. Ashby is a well-known Pharmacology professor for student pharmacists studying in their professional years. He…

15 years ago

Pharmacogenetic Applications in Clinical Practice

By: Neal Shah - The focus of pharmacy is rapidly shifting from simple filling and dispensing of prescriptions to preventative…

15 years ago

Faculty Spotlight: Dr. Parnali Chatterjee

By: Ebey P. Soman - Meet Dr. Parnali Chatterjee, a new faculty member in our St. John's University family. I…

15 years ago